Regulatory & BiostatisticsFounded 1997
NDA Group (now part of SSI Strategy)
Morristown, New Jersey, United States
Former-regulator-led regulatory affairs, pharmacovigilance, and health-technology-assessment consultancy that advises sponsors on EU and US drug development and approval strategy; merged with SSI Strategy in 2023 to form a larger transatlantic life-sciences regulatory consultancy.
- Segment
- Regulatory & Biostatistics
- Headquarters
- Morristown, New Jersey, United States
- Founded
- 1997
- Website
- ssistrategy.com
Notable facts
- Founded in Sweden in 1997 as NDA Group; merged with (was acquired by) SSI Strategy on August 15, 2023, creating a combined global life-sciences regulatory consultancy headquartered in Morristown, NJ.
- The combined entity's website lists its current headquarters in Morristown, NJ, with the original NDA Group base in Upplands Väsby, Sweden continuing as a regional office.
- Company states its consultants have 'contributed to the approval of more than a quarter of all new medicines in the US and EU over the last five years' — a self-reported claim not independently verified.
Sourcing guides
Sources. This profile is compiled from public reference data, WebSearch-verified against source 1 · source 2 · source 3. Data as of 2026-07-14. See methodology.
Sourcing a vendor in this segment today? We connect clinical operations, regulatory, and procurement teams with qualified regulatory & biostatistics vendors.
Request vendors